nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ADRB2—prostate cancer	0.413	1	CbGaD
Atenolol—ABCB1—Estramustine—prostate cancer	0.0669	0.2	CbGbCtD
Atenolol—ABCB1—Cabazitaxel—prostate cancer	0.0441	0.132	CbGbCtD
Atenolol—ABCB1—Estrone—prostate cancer	0.0431	0.129	CbGbCtD
Atenolol—ABCB1—Ethinyl Estradiol—prostate cancer	0.0384	0.115	CbGbCtD
Atenolol—ABCB1—Conjugated Estrogens—prostate cancer	0.0282	0.0843	CbGbCtD
Atenolol—ABCB1—Mitoxantrone—prostate cancer	0.0257	0.0767	CbGbCtD
Atenolol—ABCB1—Estradiol—prostate cancer	0.0248	0.074	CbGbCtD
Atenolol—ABCB1—Prednisone—prostate cancer	0.0213	0.0637	CbGbCtD
Atenolol—ABCB1—Etoposide—prostate cancer	0.0162	0.0483	CbGbCtD
Atenolol—ABCB1—Docetaxel—prostate cancer	0.0148	0.0442	CbGbCtD
Atenolol—ABCB1—Doxorubicin—prostate cancer	0.011	0.033	CbGbCtD
Atenolol—Procarbazine—CYP1B1—prostate cancer	0.00111	0.179	CrCbGaD
Atenolol—Acebutolol—SLC22A1—prostate cancer	0.000383	0.0619	CrCbGaD
Atenolol—Metipranolol—ADRB2—prostate cancer	0.000382	0.0617	CrCbGaD
Atenolol—Sotalol—ADRB2—prostate cancer	0.00034	0.055	CrCbGaD
Atenolol—Chlorphenesin—CYP19A1—prostate cancer	0.000308	0.0499	CrCbGaD
Atenolol—Esmolol—ADRB2—prostate cancer	0.000303	0.049	CrCbGaD
Atenolol—Ibuprofen—BCL2—prostate cancer	0.000271	0.0438	CrCbGaD
Atenolol—Betaxolol—ADRB2—prostate cancer	0.000267	0.0432	CrCbGaD
Atenolol—Bisoprolol—ADRB2—prostate cancer	0.000258	0.0417	CrCbGaD
Atenolol—Acebutolol—ADRB2—prostate cancer	0.000244	0.0395	CrCbGaD
Atenolol—Oxprenolol—ADRB2—prostate cancer	0.000242	0.0392	CrCbGaD
Atenolol—Alprenolol—ADRB2—prostate cancer	0.000222	0.0359	CrCbGaD
Atenolol—Ibuprofen—CXCL8—prostate cancer	0.000217	0.0351	CrCbGaD
Atenolol—Metoprolol—ADRB2—prostate cancer	0.000206	0.0333	CrCbGaD
Atenolol—Pindolol—ADRB2—prostate cancer	0.000191	0.0308	CrCbGaD
Atenolol—Metoprolol—CYP2C19—prostate cancer	0.000177	0.0287	CrCbGaD
Atenolol—Chlorphenesin—CYP3A4—prostate cancer	0.000145	0.0234	CrCbGaD
Atenolol—Chlorphenesin—PTGS2—prostate cancer	0.000142	0.0229	CrCbGaD
Atenolol—Bisoprolol—CYP3A4—prostate cancer	0.000141	0.0228	CrCbGaD
Atenolol—Propranolol—CYP3A5—prostate cancer	0.000132	0.0213	CrCbGaD
Atenolol—Propranolol—ADRB2—prostate cancer	0.000104	0.0168	CrCbGaD
Atenolol—Ibuprofen—CYP2C19—prostate cancer	0.000102	0.0164	CrCbGaD
Atenolol—Nausea—Goserelin—prostate cancer	0.000101	0.000469	CcSEcCtD
Atenolol—Hyperhidrosis—Etoposide—prostate cancer	0.000101	0.000469	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—prostate cancer	0.0001	0.000468	CcSEcCtD
Atenolol—Nausea—Conjugated Estrogens—prostate cancer	9.96e-05	0.000465	CcSEcCtD
Atenolol—Anorexia—Etoposide—prostate cancer	9.92e-05	0.000463	CcSEcCtD
Atenolol—Body temperature increased—Mitoxantrone—prostate cancer	9.89e-05	0.000461	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	9.88e-05	0.000461	CcSEcCtD
Atenolol—Flushing—Prednisone—prostate cancer	9.74e-05	0.000455	CcSEcCtD
Atenolol—Hypotension—Etoposide—prostate cancer	9.72e-05	0.000454	CcSEcCtD
Atenolol—Vision blurred—Capecitabine—prostate cancer	9.67e-05	0.000451	CcSEcCtD
Atenolol—Asthenia—Estradiol—prostate cancer	9.63e-05	0.000449	CcSEcCtD
Atenolol—Ill-defined disorder—Capecitabine—prostate cancer	9.52e-05	0.000444	CcSEcCtD
Atenolol—Syncope—Docetaxel—prostate cancer	9.5e-05	0.000443	CcSEcCtD
Atenolol—Pruritus—Estradiol—prostate cancer	9.5e-05	0.000443	CcSEcCtD
Atenolol—Arrhythmia—Prednisone—prostate cancer	9.37e-05	0.000438	CcSEcCtD
Atenolol—Palpitations—Docetaxel—prostate cancer	9.36e-05	0.000437	CcSEcCtD
Atenolol—Paraesthesia—Etoposide—prostate cancer	9.34e-05	0.000436	CcSEcCtD
Atenolol—Loss of consciousness—Docetaxel—prostate cancer	9.31e-05	0.000435	CcSEcCtD
Atenolol—Dyspnoea—Etoposide—prostate cancer	9.27e-05	0.000433	CcSEcCtD
Atenolol—Alopecia—Prednisone—prostate cancer	9.27e-05	0.000433	CcSEcCtD
Atenolol—Malaise—Capecitabine—prostate cancer	9.25e-05	0.000432	CcSEcCtD
Atenolol—Somnolence—Etoposide—prostate cancer	9.25e-05	0.000432	CcSEcCtD
Atenolol—Cough—Docetaxel—prostate cancer	9.24e-05	0.000431	CcSEcCtD
Atenolol—Vertigo—Capecitabine—prostate cancer	9.21e-05	0.00043	CcSEcCtD
Atenolol—Syncope—Capecitabine—prostate cancer	9.2e-05	0.000429	CcSEcCtD
Atenolol—Diarrhoea—Estradiol—prostate cancer	9.18e-05	0.000429	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—prostate cancer	9.14e-05	0.000427	CcSEcCtD
Atenolol—Palpitations—Capecitabine—prostate cancer	9.06e-05	0.000423	CcSEcCtD
Atenolol—Decreased appetite—Etoposide—prostate cancer	9.04e-05	0.000422	CcSEcCtD
Atenolol—Chest pain—Docetaxel—prostate cancer	9.02e-05	0.000421	CcSEcCtD
Atenolol—Loss of consciousness—Capecitabine—prostate cancer	9.01e-05	0.000421	CcSEcCtD
Atenolol—Renal failure—Epirubicin—prostate cancer	8.99e-05	0.000419	CcSEcCtD
Atenolol—Gastrointestinal disorder—Etoposide—prostate cancer	8.98e-05	0.000419	CcSEcCtD
Atenolol—Asthenia—Mitoxantrone—prostate cancer	8.97e-05	0.000419	CcSEcCtD
Atenolol—Fatigue—Etoposide—prostate cancer	8.97e-05	0.000419	CcSEcCtD
Atenolol—Propranolol—CYP2C19—prostate cancer	8.96e-05	0.0145	CrCbGaD
Atenolol—Cough—Capecitabine—prostate cancer	8.95e-05	0.000418	CcSEcCtD
Atenolol—Propranolol—CYP1A1—prostate cancer	8.92e-05	0.0144	CrCbGaD
Atenolol—Pain—Etoposide—prostate cancer	8.9e-05	0.000415	CcSEcCtD
Atenolol—Constipation—Etoposide—prostate cancer	8.9e-05	0.000415	CcSEcCtD
Atenolol—Dizziness—Estradiol—prostate cancer	8.88e-05	0.000414	CcSEcCtD
Atenolol—Dry mouth—Docetaxel—prostate cancer	8.82e-05	0.000412	CcSEcCtD
Atenolol—Sweating—Epirubicin—prostate cancer	8.76e-05	0.000409	CcSEcCtD
Atenolol—Chest pain—Capecitabine—prostate cancer	8.73e-05	0.000408	CcSEcCtD
Atenolol—Confusional state—Docetaxel—prostate cancer	8.72e-05	0.000407	CcSEcCtD
Atenolol—Anxiety—Capecitabine—prostate cancer	8.7e-05	0.000406	CcSEcCtD
Atenolol—Oedema—Docetaxel—prostate cancer	8.64e-05	0.000403	CcSEcCtD
Atenolol—Discomfort—Capecitabine—prostate cancer	8.63e-05	0.000403	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—prostate cancer	8.62e-05	0.000402	CcSEcCtD
Atenolol—Vision blurred—Prednisone—prostate cancer	8.61e-05	0.000402	CcSEcCtD
Atenolol—Feeling abnormal—Etoposide—prostate cancer	8.57e-05	0.0004	CcSEcCtD
Atenolol—Diarrhoea—Mitoxantrone—prostate cancer	8.56e-05	0.000399	CcSEcCtD
Atenolol—Dry mouth—Capecitabine—prostate cancer	8.54e-05	0.000399	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—prostate cancer	8.53e-05	0.000398	CcSEcCtD
Atenolol—Shock—Docetaxel—prostate cancer	8.51e-05	0.000397	CcSEcCtD
Atenolol—Ill-defined disorder—Prednisone—prostate cancer	8.48e-05	0.000396	CcSEcCtD
Atenolol—Thrombocytopenia—Docetaxel—prostate cancer	8.46e-05	0.000395	CcSEcCtD
Atenolol—Rash—Estradiol—prostate cancer	8.46e-05	0.000395	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—prostate cancer	8.46e-05	0.000395	CcSEcCtD
Atenolol—Dermatitis—Estradiol—prostate cancer	8.45e-05	0.000395	CcSEcCtD
Atenolol—Confusional state—Capecitabine—prostate cancer	8.44e-05	0.000394	CcSEcCtD
Atenolol—Tachycardia—Docetaxel—prostate cancer	8.44e-05	0.000394	CcSEcCtD
Atenolol—Headache—Estradiol—prostate cancer	8.41e-05	0.000392	CcSEcCtD
Atenolol—Oedema—Capecitabine—prostate cancer	8.37e-05	0.000391	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—prostate cancer	8.36e-05	0.00039	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—prostate cancer	8.32e-05	0.000388	CcSEcCtD
Atenolol—Anorexia—Docetaxel—prostate cancer	8.24e-05	0.000385	CcSEcCtD
Atenolol—Malaise—Prednisone—prostate cancer	8.24e-05	0.000384	CcSEcCtD
Atenolol—Shock—Capecitabine—prostate cancer	8.23e-05	0.000384	CcSEcCtD
Atenolol—Body temperature increased—Etoposide—prostate cancer	8.22e-05	0.000384	CcSEcCtD
Atenolol—Vertigo—Prednisone—prostate cancer	8.21e-05	0.000383	CcSEcCtD
Atenolol—Thrombocytopenia—Capecitabine—prostate cancer	8.19e-05	0.000382	CcSEcCtD
Atenolol—Syncope—Prednisone—prostate cancer	8.19e-05	0.000382	CcSEcCtD
Atenolol—Tachycardia—Capecitabine—prostate cancer	8.17e-05	0.000381	CcSEcCtD
Atenolol—Sweating—Doxorubicin—prostate cancer	8.11e-05	0.000379	CcSEcCtD
Atenolol—Hyperhidrosis—Capecitabine—prostate cancer	8.09e-05	0.000378	CcSEcCtD
Atenolol—Hypotension—Docetaxel—prostate cancer	8.08e-05	0.000377	CcSEcCtD
Atenolol—Loss of consciousness—Prednisone—prostate cancer	8.03e-05	0.000375	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—prostate cancer	7.98e-05	0.000372	CcSEcCtD
Atenolol—Anorexia—Capecitabine—prostate cancer	7.98e-05	0.000372	CcSEcCtD
Atenolol—Nausea—Estradiol—prostate cancer	7.97e-05	0.000372	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—prostate cancer	7.91e-05	0.000369	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—prostate cancer	7.89e-05	0.000368	CcSEcCtD
Atenolol—Rash—Mitoxantrone—prostate cancer	7.89e-05	0.000368	CcSEcCtD
Atenolol—Dermatitis—Mitoxantrone—prostate cancer	7.88e-05	0.000368	CcSEcCtD
Atenolol—Headache—Mitoxantrone—prostate cancer	7.83e-05	0.000366	CcSEcCtD
Atenolol—Hypotension—Capecitabine—prostate cancer	7.82e-05	0.000365	CcSEcCtD
Atenolol—Insomnia—Docetaxel—prostate cancer	7.82e-05	0.000365	CcSEcCtD
Atenolol—Paraesthesia—Docetaxel—prostate cancer	7.76e-05	0.000362	CcSEcCtD
Atenolol—Anxiety—Prednisone—prostate cancer	7.75e-05	0.000362	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—prostate cancer	7.73e-05	0.000361	CcSEcCtD
Atenolol—Dyspnoea—Docetaxel—prostate cancer	7.71e-05	0.00036	CcSEcCtD
Atenolol—Somnolence—Docetaxel—prostate cancer	7.69e-05	0.000359	CcSEcCtD
Atenolol—Discomfort—Prednisone—prostate cancer	7.68e-05	0.000359	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—prostate cancer	7.65e-05	0.000357	CcSEcCtD
Atenolol—Flushing—Epirubicin—prostate cancer	7.62e-05	0.000356	CcSEcCtD
Atenolol—Dyspepsia—Docetaxel—prostate cancer	7.61e-05	0.000355	CcSEcCtD
Atenolol—Insomnia—Capecitabine—prostate cancer	7.57e-05	0.000353	CcSEcCtD
Atenolol—Paraesthesia—Capecitabine—prostate cancer	7.52e-05	0.000351	CcSEcCtD
Atenolol—Decreased appetite—Docetaxel—prostate cancer	7.51e-05	0.000351	CcSEcCtD
Atenolol—Gastrointestinal disorder—Docetaxel—prostate cancer	7.46e-05	0.000348	CcSEcCtD
Atenolol—Asthenia—Etoposide—prostate cancer	7.46e-05	0.000348	CcSEcCtD
Atenolol—Dyspnoea—Capecitabine—prostate cancer	7.46e-05	0.000348	CcSEcCtD
Atenolol—Oedema—Prednisone—prostate cancer	7.46e-05	0.000348	CcSEcCtD
Atenolol—Fatigue—Docetaxel—prostate cancer	7.45e-05	0.000348	CcSEcCtD
Atenolol—Nausea—Mitoxantrone—prostate cancer	7.43e-05	0.000347	CcSEcCtD
Atenolol—Pain—Docetaxel—prostate cancer	7.39e-05	0.000345	CcSEcCtD
Atenolol—Constipation—Docetaxel—prostate cancer	7.39e-05	0.000345	CcSEcCtD
Atenolol—Dyspepsia—Capecitabine—prostate cancer	7.37e-05	0.000344	CcSEcCtD
Atenolol—Pruritus—Etoposide—prostate cancer	7.36e-05	0.000343	CcSEcCtD
Atenolol—Shock—Prednisone—prostate cancer	7.33e-05	0.000342	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—prostate cancer	7.33e-05	0.000342	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—prostate cancer	7.32e-05	0.000342	CcSEcCtD
Atenolol—Tachycardia—Prednisone—prostate cancer	7.28e-05	0.00034	CcSEcCtD
Atenolol—Decreased appetite—Capecitabine—prostate cancer	7.28e-05	0.00034	CcSEcCtD
Atenolol—Alopecia—Epirubicin—prostate cancer	7.25e-05	0.000338	CcSEcCtD
Atenolol—Gastrointestinal disorder—Capecitabine—prostate cancer	7.23e-05	0.000337	CcSEcCtD
Atenolol—Fatigue—Capecitabine—prostate cancer	7.22e-05	0.000337	CcSEcCtD
Atenolol—Hyperhidrosis—Prednisone—prostate cancer	7.21e-05	0.000336	CcSEcCtD
Atenolol—Constipation—Capecitabine—prostate cancer	7.16e-05	0.000334	CcSEcCtD
Atenolol—Pain—Capecitabine—prostate cancer	7.16e-05	0.000334	CcSEcCtD
Atenolol—Feeling abnormal—Docetaxel—prostate cancer	7.12e-05	0.000332	CcSEcCtD
Atenolol—Diarrhoea—Etoposide—prostate cancer	7.12e-05	0.000332	CcSEcCtD
Atenolol—Anorexia—Prednisone—prostate cancer	7.11e-05	0.000332	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—prostate cancer	7.08e-05	0.00033	CcSEcCtD
Atenolol—Flushing—Doxorubicin—prostate cancer	7.05e-05	0.000329	CcSEcCtD
Atenolol—Tension—Epirubicin—prostate cancer	7.01e-05	0.000327	CcSEcCtD
Atenolol—Nervousness—Epirubicin—prostate cancer	6.94e-05	0.000324	CcSEcCtD
Atenolol—Feeling abnormal—Capecitabine—prostate cancer	6.9e-05	0.000322	CcSEcCtD
Atenolol—Dizziness—Etoposide—prostate cancer	6.88e-05	0.000321	CcSEcCtD
Atenolol—Body temperature increased—Docetaxel—prostate cancer	6.83e-05	0.000319	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—prostate cancer	6.78e-05	0.000317	CcSEcCtD
Atenolol—Insomnia—Prednisone—prostate cancer	6.74e-05	0.000315	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—prostate cancer	6.73e-05	0.000314	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—prostate cancer	6.71e-05	0.000313	CcSEcCtD
Atenolol—Paraesthesia—Prednisone—prostate cancer	6.69e-05	0.000312	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—prostate cancer	6.63e-05	0.000309	CcSEcCtD
Atenolol—Body temperature increased—Capecitabine—prostate cancer	6.62e-05	0.000309	CcSEcCtD
Atenolol—Dyspepsia—Prednisone—prostate cancer	6.56e-05	0.000306	CcSEcCtD
Atenolol—Rash—Etoposide—prostate cancer	6.56e-05	0.000306	CcSEcCtD
Atenolol—Dermatitis—Etoposide—prostate cancer	6.55e-05	0.000306	CcSEcCtD
Atenolol—Headache—Etoposide—prostate cancer	6.52e-05	0.000304	CcSEcCtD
Atenolol—Tension—Doxorubicin—prostate cancer	6.49e-05	0.000303	CcSEcCtD
Atenolol—Decreased appetite—Prednisone—prostate cancer	6.48e-05	0.000302	CcSEcCtD
Atenolol—Malaise—Epirubicin—prostate cancer	6.44e-05	0.000301	CcSEcCtD
Atenolol—Fatigue—Prednisone—prostate cancer	6.43e-05	0.0003	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—prostate cancer	6.42e-05	0.0003	CcSEcCtD
Atenolol—Vertigo—Epirubicin—prostate cancer	6.42e-05	0.0003	CcSEcCtD
Atenolol—Syncope—Epirubicin—prostate cancer	6.41e-05	0.000299	CcSEcCtD
Atenolol—Constipation—Prednisone—prostate cancer	6.38e-05	0.000298	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—prostate cancer	6.33e-05	0.0102	CrCbGaD
Atenolol—Palpitations—Epirubicin—prostate cancer	6.31e-05	0.000295	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—prostate cancer	6.28e-05	0.000293	CcSEcCtD
Atenolol—Cough—Epirubicin—prostate cancer	6.23e-05	0.000291	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—prostate cancer	6.23e-05	0.000291	CcSEcCtD
Atenolol—Asthenia—Docetaxel—prostate cancer	6.2e-05	0.000289	CcSEcCtD
Atenolol—Nausea—Etoposide—prostate cancer	6.18e-05	0.000288	CcSEcCtD
Atenolol—Feeling abnormal—Prednisone—prostate cancer	6.14e-05	0.000287	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—prostate cancer	6.13e-05	0.000286	CcSEcCtD
Atenolol—Pruritus—Docetaxel—prostate cancer	6.12e-05	0.000285	CcSEcCtD
Atenolol—Chest pain—Epirubicin—prostate cancer	6.08e-05	0.000284	CcSEcCtD
Atenolol—Anxiety—Epirubicin—prostate cancer	6.06e-05	0.000283	CcSEcCtD
Atenolol—Discomfort—Epirubicin—prostate cancer	6.01e-05	0.00028	CcSEcCtD
Atenolol—Asthenia—Capecitabine—prostate cancer	6.01e-05	0.00028	CcSEcCtD
Atenolol—Malaise—Doxorubicin—prostate cancer	5.96e-05	0.000278	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—prostate cancer	5.95e-05	0.000278	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—prostate cancer	5.94e-05	0.000277	CcSEcCtD
Atenolol—Syncope—Doxorubicin—prostate cancer	5.93e-05	0.000277	CcSEcCtD
Atenolol—Pruritus—Capecitabine—prostate cancer	5.92e-05	0.000276	CcSEcCtD
Atenolol—Diarrhoea—Docetaxel—prostate cancer	5.91e-05	0.000276	CcSEcCtD
Atenolol—Body temperature increased—Prednisone—prostate cancer	5.89e-05	0.000275	CcSEcCtD
Atenolol—Confusional state—Epirubicin—prostate cancer	5.88e-05	0.000274	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—prostate cancer	5.84e-05	0.000273	CcSEcCtD
Atenolol—Oedema—Epirubicin—prostate cancer	5.83e-05	0.000272	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—prostate cancer	5.81e-05	0.000271	CcSEcCtD
Atenolol—Cough—Doxorubicin—prostate cancer	5.77e-05	0.000269	CcSEcCtD
Atenolol—Shock—Epirubicin—prostate cancer	5.74e-05	0.000268	CcSEcCtD
Atenolol—Diarrhoea—Capecitabine—prostate cancer	5.73e-05	0.000267	CcSEcCtD
Atenolol—Dizziness—Docetaxel—prostate cancer	5.72e-05	0.000267	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—prostate cancer	5.71e-05	0.000266	CcSEcCtD
Atenolol—Propranolol—CYP3A4—prostate cancer	5.7e-05	0.00921	CrCbGaD
Atenolol—Tachycardia—Epirubicin—prostate cancer	5.69e-05	0.000266	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—prostate cancer	5.64e-05	0.000263	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—prostate cancer	5.63e-05	0.000263	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—prostate cancer	5.61e-05	0.000262	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—prostate cancer	5.56e-05	0.00026	CcSEcCtD
Atenolol—Anorexia—Epirubicin—prostate cancer	5.56e-05	0.000259	CcSEcCtD
Atenolol—Dizziness—Capecitabine—prostate cancer	5.53e-05	0.000258	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—prostate cancer	5.5e-05	0.000257	CcSEcCtD
Atenolol—Rash—Docetaxel—prostate cancer	5.45e-05	0.000254	CcSEcCtD
Atenolol—Hypotension—Epirubicin—prostate cancer	5.45e-05	0.000254	CcSEcCtD
Atenolol—Dermatitis—Docetaxel—prostate cancer	5.45e-05	0.000254	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—prostate cancer	5.44e-05	0.000254	CcSEcCtD
Atenolol—Headache—Docetaxel—prostate cancer	5.42e-05	0.000253	CcSEcCtD
Atenolol—Oedema—Doxorubicin—prostate cancer	5.4e-05	0.000252	CcSEcCtD
Atenolol—Asthenia—Prednisone—prostate cancer	5.35e-05	0.00025	CcSEcCtD
Atenolol—Shock—Doxorubicin—prostate cancer	5.31e-05	0.000248	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—prostate cancer	5.28e-05	0.000247	CcSEcCtD
Atenolol—Rash—Capecitabine—prostate cancer	5.28e-05	0.000246	CcSEcCtD
Atenolol—Pruritus—Prednisone—prostate cancer	5.27e-05	0.000246	CcSEcCtD
Atenolol—Insomnia—Epirubicin—prostate cancer	5.27e-05	0.000246	CcSEcCtD
Atenolol—Dermatitis—Capecitabine—prostate cancer	5.27e-05	0.000246	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—prostate cancer	5.27e-05	0.000246	CcSEcCtD
Atenolol—Headache—Capecitabine—prostate cancer	5.24e-05	0.000245	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—prostate cancer	5.24e-05	0.000244	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—prostate cancer	5.22e-05	0.000243	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—prostate cancer	5.2e-05	0.000243	CcSEcCtD
Atenolol—Somnolence—Epirubicin—prostate cancer	5.18e-05	0.000242	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—prostate cancer	5.14e-05	0.00024	CcSEcCtD
Atenolol—Nausea—Docetaxel—prostate cancer	5.13e-05	0.00024	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—prostate cancer	5.13e-05	0.00024	CcSEcCtD
Atenolol—Diarrhoea—Prednisone—prostate cancer	5.1e-05	0.000238	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—prostate cancer	5.07e-05	0.000237	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—prostate cancer	5.04e-05	0.000235	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—prostate cancer	5.03e-05	0.000235	CcSEcCtD
Atenolol—Fatigue—Epirubicin—prostate cancer	5.03e-05	0.000235	CcSEcCtD
Atenolol—Pain—Epirubicin—prostate cancer	4.99e-05	0.000233	CcSEcCtD
Atenolol—Constipation—Epirubicin—prostate cancer	4.99e-05	0.000233	CcSEcCtD
Atenolol—Nausea—Capecitabine—prostate cancer	4.97e-05	0.000232	CcSEcCtD
Atenolol—Dizziness—Prednisone—prostate cancer	4.93e-05	0.00023	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—prostate cancer	4.88e-05	0.000228	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—prostate cancer	4.84e-05	0.000226	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—prostate cancer	4.81e-05	0.000225	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—prostate cancer	4.8e-05	0.000224	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—prostate cancer	4.8e-05	0.000224	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—prostate cancer	4.75e-05	0.000222	CcSEcCtD
Atenolol—Rash—Prednisone—prostate cancer	4.7e-05	0.000219	CcSEcCtD
Atenolol—Dermatitis—Prednisone—prostate cancer	4.7e-05	0.000219	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—prostate cancer	4.69e-05	0.000219	CcSEcCtD
Atenolol—Headache—Prednisone—prostate cancer	4.67e-05	0.000218	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.66e-05	0.000217	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—prostate cancer	4.65e-05	0.000217	CcSEcCtD
Atenolol—Pain—Doxorubicin—prostate cancer	4.61e-05	0.000215	CcSEcCtD
Atenolol—Constipation—Doxorubicin—prostate cancer	4.61e-05	0.000215	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—prostate cancer	4.61e-05	0.000215	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—prostate cancer	4.45e-05	0.000208	CcSEcCtD
Atenolol—Nausea—Prednisone—prostate cancer	4.43e-05	0.000207	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—prostate cancer	4.26e-05	0.000199	CcSEcCtD
Atenolol—Asthenia—Epirubicin—prostate cancer	4.18e-05	0.000195	CcSEcCtD
Atenolol—Pruritus—Epirubicin—prostate cancer	4.13e-05	0.000193	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—prostate cancer	3.99e-05	0.000186	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—prostate cancer	3.87e-05	0.000181	CcSEcCtD
Atenolol—Dizziness—Epirubicin—prostate cancer	3.86e-05	0.00018	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—prostate cancer	3.82e-05	0.000178	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—prostate cancer	3.69e-05	0.000172	CcSEcCtD
Atenolol—Rash—Epirubicin—prostate cancer	3.68e-05	0.000172	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—prostate cancer	3.67e-05	0.000171	CcSEcCtD
Atenolol—Headache—Epirubicin—prostate cancer	3.65e-05	0.00017	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—prostate cancer	3.57e-05	0.000167	CcSEcCtD
Atenolol—Nausea—Epirubicin—prostate cancer	3.46e-05	0.000162	CcSEcCtD
Atenolol—Rash—Doxorubicin—prostate cancer	3.4e-05	0.000159	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—prostate cancer	3.4e-05	0.000159	CcSEcCtD
Atenolol—Headache—Doxorubicin—prostate cancer	3.38e-05	0.000158	CcSEcCtD
Atenolol—Nausea—Doxorubicin—prostate cancer	3.2e-05	0.00015	CcSEcCtD
Atenolol—ABCB1—Metabolism—UCP3—prostate cancer	1.27e-05	0.000395	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TCN2—prostate cancer	1.27e-05	0.000395	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTA3—prostate cancer	1.27e-05	0.000395	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	1.27e-05	0.000394	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKACB—prostate cancer	1.26e-05	0.000392	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—THBS1—prostate cancer	1.26e-05	0.000391	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PPP3CA—prostate cancer	1.26e-05	0.000391	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ANXA1—prostate cancer	1.24e-05	0.000385	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—THBS1—prostate cancer	1.23e-05	0.000382	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	1.23e-05	0.000382	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRKCZ—prostate cancer	1.21e-05	0.000378	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC22A3—prostate cancer	1.21e-05	0.000377	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD3B1—prostate cancer	1.21e-05	0.000377	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ANXA1—prostate cancer	1.21e-05	0.000377	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	1.19e-05	0.00037	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CG—prostate cancer	1.19e-05	0.00037	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGFR4—prostate cancer	1.17e-05	0.000365	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PARP1—prostate cancer	1.17e-05	0.000365	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.17e-05	0.000365	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.17e-05	0.000364	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	1.16e-05	0.000362	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TBXAS1—prostate cancer	1.16e-05	0.000362	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTA4—prostate cancer	1.16e-05	0.000362	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CALCA—prostate cancer	1.16e-05	0.000361	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PARP1—prostate cancer	1.15e-05	0.000357	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGFR4—prostate cancer	1.15e-05	0.000357	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.15e-05	0.000357	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CALCA—prostate cancer	1.13e-05	0.000353	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTA2—prostate cancer	1.13e-05	0.000352	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL12—prostate cancer	1.13e-05	0.000352	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCG5—prostate cancer	1.12e-05	0.000348	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SULT1A1—prostate cancer	1.12e-05	0.000348	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL12—prostate cancer	1.11e-05	0.000345	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTA1—prostate cancer	1.09e-05	0.00034	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.08e-05	0.000337	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD3B2—prostate cancer	1.08e-05	0.000336	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTO1—prostate cancer	1.08e-05	0.000336	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NAT2—prostate cancer	1.08e-05	0.000336	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CG—prostate cancer	1.08e-05	0.000336	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP9—prostate cancer	1.07e-05	0.000332	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	1.05e-05	0.000328	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CD—prostate cancer	1.04e-05	0.000325	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP9—prostate cancer	1.04e-05	0.000325	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLCB2—prostate cancer	1.03e-05	0.000322	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LRP2—prostate cancer	1.03e-05	0.000322	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP2C18—prostate cancer	1.03e-05	0.000322	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRKCQ—prostate cancer	1.03e-05	0.000322	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NGFR—prostate cancer	1.03e-05	0.000322	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	1.02e-05	0.000318	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAP3K7—prostate cancer	1.02e-05	0.000318	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—P4HB—prostate cancer	1.01e-05	0.000316	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	1.01e-05	0.000315	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NGFR—prostate cancer	1.01e-05	0.000315	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	9.98e-06	0.000311	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	9.94e-06	0.00031	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC22A1—prostate cancer	9.87e-06	0.000307	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	9.87e-06	0.000307	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF10—prostate cancer	9.81e-06	0.000306	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRB2—prostate cancer	9.71e-06	0.000302	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SULT2A1—prostate cancer	9.62e-06	0.0003	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	9.62e-06	0.0003	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF10—prostate cancer	9.6e-06	0.000299	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—JAK2—prostate cancer	9.58e-06	0.000298	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAP2K1—prostate cancer	9.54e-06	0.000297	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CD—prostate cancer	9.48e-06	0.000295	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VAV3—prostate cancer	9.47e-06	0.000295	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MED12—prostate cancer	9.47e-06	0.000295	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GNG5—prostate cancer	9.39e-06	0.000292	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	9.37e-06	0.000292	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFBR2—prostate cancer	9.33e-06	0.000291	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	9.33e-06	0.000291	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	9.27e-06	0.000289	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VAV3—prostate cancer	9.26e-06	0.000288	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ITPR1—prostate cancer	9.18e-06	0.000286	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	9.13e-06	0.000284	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CB—prostate cancer	9.1e-06	0.000283	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA3—prostate cancer	9.05e-06	0.000282	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ITPR1—prostate cancer	8.98e-06	0.00028	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	8.9e-06	0.000277	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1R—prostate cancer	8.78e-06	0.000273	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	8.74e-06	0.000272	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—JAK2—prostate cancer	8.7e-06	0.000271	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HPGDS—prostate cancer	8.63e-06	0.000269	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1R—prostate cancer	8.59e-06	0.000267	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP2C19—prostate cancer	8.58e-06	0.000267	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	8.55e-06	0.000266	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—JAK2—prostate cancer	8.51e-06	0.000265	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LPL—prostate cancer	8.42e-06	0.000262	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ACHE—prostate cancer	8.37e-06	0.000261	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTT1—prostate cancer	8.37e-06	0.000261	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IL2—prostate cancer	8.35e-06	0.00026	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	8.34e-06	0.00026	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP2A6—prostate cancer	8.27e-06	0.000258	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	8.26e-06	0.000257	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LPL—prostate cancer	8.23e-06	0.000256	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	8.17e-06	0.000254	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	8.16e-06	0.000254	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	8.13e-06	0.000253	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	8.12e-06	0.000253	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	8.08e-06	0.000252	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKR1C3—prostate cancer	8.05e-06	0.000251	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PRKACB—prostate cancer	8.01e-06	0.000249	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	7.95e-06	0.000248	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	7.94e-06	0.000247	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP17A1—prostate cancer	7.92e-06	0.000247	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	7.89e-06	0.000246	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	7.87e-06	0.000245	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.84e-06	0.000244	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	7.76e-06	0.000242	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	7.71e-06	0.00024	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	7.7e-06	0.00024	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL2—prostate cancer	7.59e-06	0.000236	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TERT—prostate cancer	7.56e-06	0.000235	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA2—prostate cancer	7.55e-06	0.000235	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	7.42e-06	0.000231	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TERT—prostate cancer	7.39e-06	0.00023	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	7.23e-06	0.000225	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC5A5—prostate cancer	7.2e-06	0.000224	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	7.07e-06	0.00022	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LEP—prostate cancer	7.06e-06	0.00022	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP2E1—prostate cancer	7.04e-06	0.000219	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	6.99e-06	0.000218	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NQO1—prostate cancer	6.96e-06	0.000217	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KDR—prostate cancer	6.91e-06	0.000215	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LEP—prostate cancer	6.9e-06	0.000215	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TH—prostate cancer	6.86e-06	0.000213	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	6.84e-06	0.000213	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP3A4—prostate cancer	6.78e-06	0.000211	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KDR—prostate cancer	6.76e-06	0.000211	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	6.74e-06	0.00021	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP1B1—prostate cancer	6.67e-06	0.000208	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	6.59e-06	0.000205	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—BAD—prostate cancer	6.58e-06	0.000205	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GGT1—prostate cancer	6.46e-06	0.000201	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—BAD—prostate cancer	6.43e-06	0.0002	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APC—prostate cancer	6.37e-06	0.000198	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	6.37e-06	0.000198	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA1—prostate cancer	6.36e-06	0.000198	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGF—prostate cancer	6.29e-06	0.000196	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	6.29e-06	0.000196	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP19A1—prostate cancer	6.27e-06	0.000195	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	6.23e-06	0.000194	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APC—prostate cancer	6.23e-06	0.000194	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGF—prostate cancer	6.16e-06	0.000192	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	6.16e-06	0.000192	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	6.11e-06	0.00019	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—RXRA—prostate cancer	6.05e-06	0.000188	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INS—prostate cancer	6.03e-06	0.000188	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	5.98e-06	0.000186	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	5.9e-06	0.000184	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INS—prostate cancer	5.9e-06	0.000184	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	5.83e-06	0.000182	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—COMT—prostate cancer	5.83e-06	0.000182	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTP1—prostate cancer	5.8e-06	0.000181	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	5.8e-06	0.000181	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	5.78e-06	0.00018	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ITPR1—prostate cancer	5.71e-06	0.000178	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	5.7e-06	0.000178	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	5.68e-06	0.000177	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	5.64e-06	0.000175	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	5.6e-06	0.000174	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	5.54e-06	0.000173	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	5.54e-06	0.000172	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	5.51e-06	0.000172	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	5.48e-06	0.000171	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	5.48e-06	0.000171	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	5.42e-06	0.000169	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	5.42e-06	0.000169	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TYMS—prostate cancer	5.39e-06	0.000168	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	5.36e-06	0.000167	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	5.36e-06	0.000167	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTM1—prostate cancer	5.33e-06	0.000166	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	5.29e-06	0.000165	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	5.24e-06	0.000163	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LPL—prostate cancer	5.23e-06	0.000163	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	5.17e-06	0.000161	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	5.14e-06	0.00016	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP1A1—prostate cancer	5.05e-06	0.000157	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	5.04e-06	0.000157	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	5.03e-06	0.000156	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	5.02e-06	0.000156	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ERCC2—prostate cancer	5.01e-06	0.000156	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	4.94e-06	0.000154	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	4.93e-06	0.000153	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	4.91e-06	0.000153	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	4.88e-06	0.000152	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	4.84e-06	0.000151	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	4.77e-06	0.000149	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTHFR—prostate cancer	4.71e-06	0.000147	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	4.69e-06	0.000146	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARA—prostate cancer	4.62e-06	0.000144	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	4.59e-06	0.000143	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	4.58e-06	0.000143	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	4.53e-06	0.000141	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	4.49e-06	0.00014	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL2—prostate cancer	4.48e-06	0.00014	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	4.48e-06	0.000139	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	4.46e-06	0.000139	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	4.43e-06	0.000138	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	4.39e-06	0.000137	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL2—prostate cancer	4.38e-06	0.000137	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	4.37e-06	0.000136	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	4.36e-06	0.000136	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CAV1—prostate cancer	4.35e-06	0.000135	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	4.33e-06	0.000135	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	4.27e-06	0.000133	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	4.24e-06	0.000132	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	4.23e-06	0.000132	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	4.23e-06	0.000132	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	4.22e-06	0.000131	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	4.15e-06	0.000129	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	4.13e-06	0.000129	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	4.12e-06	0.000128	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	4.11e-06	0.000128	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	4.02e-06	0.000125	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EP300—prostate cancer	4.02e-06	0.000125	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CG—prostate cancer	3.96e-06	0.000123	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EP300—prostate cancer	3.93e-06	0.000122	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SRC—prostate cancer	3.91e-06	0.000122	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SRC—prostate cancer	3.83e-06	0.000119	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	3.81e-06	0.000119	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	3.77e-06	0.000117	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—INS—prostate cancer	3.75e-06	0.000117	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	3.73e-06	0.000116	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	3.69e-06	0.000115	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CREBBP—prostate cancer	3.67e-06	0.000114	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MYC—prostate cancer	3.5e-06	0.000109	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	3.5e-06	0.000109	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CD—prostate cancer	3.48e-06	0.000108	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MYC—prostate cancer	3.43e-06	0.000107	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	3.43e-06	0.000107	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	3.42e-06	0.000106	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	3.35e-06	0.000104	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NOS3—prostate cancer	3.29e-06	0.000102	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	3.24e-06	0.000101	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	3.17e-06	9.86e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CB—prostate cancer	3.03e-06	9.45e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS2—prostate cancer	3.01e-06	9.36e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	2.97e-06	9.26e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	2.91e-06	9.06e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TP53—prostate cancer	2.88e-06	8.96e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TP53—prostate cancer	2.81e-06	8.77e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—prostate cancer	2.63e-06	8.2e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTEN—prostate cancer	2.62e-06	8.16e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—prostate cancer	2.58e-06	8.02e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—EP300—prostate cancer	2.5e-06	7.78e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	2.43e-06	7.57e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	2.38e-06	7.4e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CA—prostate cancer	1.85e-06	5.76e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—prostate cancer	1.51e-06	4.7e-05	CbGpPWpGaD
